Search - tctmd.com

Displaying 221 - 233 of 233

Sort: Relevancy | Date

Presentation TCT 2012

Acute Coronary Syndromes: NSTEMI

Presenter: Duane Pinto

October 21, 2012

Presentation

Bivalirudin vs. Heparin Plus a GPI in Pts with NSTEMI Undergoing PCI After Clopidogrel Pretreatment

Presenter: G. Ndrepepa

October 18, 2012

Presentation

Use of Invasive Strategy in NSTEMI Is a Major Determinant of Improved Long-term Survival

Presenter: E. Puymirat

September 17, 2012

Presentation

Polyvascular Disease and Long-term Cardiovascular Outcomes in Older Patients with NSTEMI

Presenter: S. Subherwal

July 02, 2012

Presentation

Prognostic Value of High On-Clopidogrel Platelet Reactivity in Bivalirudin- vs. Abciximab-Treated NSTEMI Patients

Presenter: Dirk Sibbing

June 06, 2012

Presentation TCTAP 2012

Evidence-Based Pharmacotherapy Recommendations for PCI, NSTEMI, and STEMI:

Presenter: Gregg W. Stone

April 26, 2012

Presentation Fellows 2012

Management of Unstable Angina and NSTEMI: Guidelines, Clinical Studies, and Real-World Performance

Presenter: George Dangas

April 21, 2012

Presentation PCI Outcomes 2012

PCI in NSTEMI and STEMI: Essentials of Pharmacology

Presenter: C. Michael Gibson

March 23, 2012

Presentation

Relación Hemorragia Grave Hospitalaria/Mortalidad a Corto, Medio y Largo en Pacientes Ancianos con NSTEMI

Presenter: R. Lopes

March 08, 2012

Presentation

Association of In-Hospital Major Bleeding with Short-, Intermediate-, and Long-term Mortality Among Older NSTEMI Patients

Presenter: Renato D. Lopes

March 08, 2012

Presentation CTO 2012

An NSTEMI Case Complicated with LMT Subtotal Occlusion and RCA CTO

Presenter: Hidetsugu Sakai

February 24, 2012

Presentation CTO 2012

Unprotected Left Main PCI in STEMI and NSTEMI

Presenter: Giovanni Pedrazzini

February 23, 2012

Presentation TCT 2012

12-month Mortality of NSTEMI Patients Treated by PCI with Multivessel Disease and Chronic Total Occlusions - Analysis from the PL-ACS Registry.

Presenter: Mateusz Tajstra, Marek Gierlotka, Mariusz Gasior, Michal Hawranek, Jacek Piegza, Krzysztof Wilczek, Lech Polonski

January 03, 2012

Advertisement

Acute Coronary Syndromes: NSTEMI

Bivalirudin vs. Heparin Plus a GPI in Pts with NSTEMI Undergoing PCI After Clopidogrel Pretreatment

Use of Invasive Strategy in NSTEMI Is a Major Determinant of Improved Long-term Survival

Polyvascular Disease and Long-term Cardiovascular Outcomes in Older Patients with NSTEMI

Prognostic Value of High On-Clopidogrel Platelet Reactivity in Bivalirudin- vs. Abciximab-Treated NSTEMI Patients

Evidence-Based Pharmacotherapy Recommendations for PCI, NSTEMI, and STEMI:

Management of Unstable Angina and NSTEMI: Guidelines, Clinical Studies, and Real-World Performance

PCI in NSTEMI and STEMI: Essentials of Pharmacology

Relación Hemorragia Grave Hospitalaria/Mortalidad a Corto, Medio y Largo en Pacientes Ancianos con NSTEMI

Association of In-Hospital Major Bleeding with Short-, Intermediate-, and Long-term Mortality Among Older NSTEMI Patients

An NSTEMI Case Complicated with LMT Subtotal Occlusion and RCA CTO

Unprotected Left Main PCI in STEMI and NSTEMI

12-month Mortality of NSTEMI Patients Treated by PCI with Multivessel Disease and Chronic Total Occlusions - Analysis from the PL-ACS Registry.

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content